Literature DB >> 16333321

Hsp90: a chaperone for protein folding and gene regulation.

Rongmin Zhao1, Walid A Houry.   

Abstract

Molecular chaperones are essential components of a quality control machinery present in the cell. They can either aid in the folding and maintenance of newly translated proteins, or they can lead to the degradation of misfolded and destabilized proteins. Hsp90 is a key member of this machinery. It is a ubiquitous molecular chaperone that is found in eubacteria and all branches of eukarya. It plays a central role in cellular signaling since it is essential for maintaining the activity of several signaling proteins, including steroid hormone receptors and protein kinases. Hsp90 is currently a novel anticancer drug target since it is overexpressed in some cancer cells. The chaperone typically functions as part of large complexes, which include other chaperones and essential cofactors that regulate its function. It is thought that different cofactors target Hsp90 to different sets of substrates. However, the mechanism of Hsp90 function remains poorly understood. As part of an effort to elucidate the Hsp90 chaperone network, we carried out a large-scale proteomics study to identify physical and genetic interactors of the chaperone. We identified 2 highly conserved novel Hsp90 cofactors, termed Tah1 and Pih1, that bind to the chaperone and that also associate physically and functionally with the essential DNA helicases Rvb1 and Rvb2. These helicases are key components of the chromatin remodeling complexes Ino80 and SWR-C. Tah1 and Pih1 seem to represent a novel class of Hsp90 cofactors that allow the chaperone to indirectly affect gene regulation in the cell in addition to its ability to directly promote protein folding. In this review, we provide an overview of Hsp90 structure and function, and we discuss the literature that links the chaperone activity to gene regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333321     DOI: 10.1139/o05-158

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  56 in total

Review 1.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights.

Authors:  Mikko Taipale; Daniel F Jarosz; Susan Lindquist
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-09       Impact factor: 94.444

2.  The Rim Pathway Mediates Antifungal Tolerance in Candida albicans through Newly Identified Rim101 Transcriptional Targets, Including Hsp90 and Ipt1.

Authors:  Cécile Garnaud; Encar García-Oliver; Yan Wang; Danièle Maubon; Sébastien Bailly; Quentin Despinasse; Morgane Champleboux; Jérôme Govin; Muriel Cornet
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  Expression of heat shock protein 70 in the thermally stressed antarctic clam Laternula elliptica.

Authors:  Hyun Park; In-Young Ahn; Hye Eun Lee
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

Review 4.  The activities and function of molecular chaperones in the endoplasmic reticulum.

Authors:  Teresa M Buck; Christine M Wright; Jeffrey L Brodsky
Journal:  Semin Cell Dev Biol       Date:  2007-09-08       Impact factor: 7.727

Review 5.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

6.  Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics.

Authors:  Michael R Defee; Zhiqiang Qin; Lu Dai; Jennifer S Isaacs; Chris H Parsons
Journal:  Am J Cancer Res       Date:  2011-06-05       Impact factor: 6.166

7.  Regulation of proto-oncogenic dbl by chaperone-controlled, ubiquitin-mediated degradation.

Authors:  Elena Kamynina; Krista Kauppinen; Faping Duan; Nora Muakkassa; Danny Manor
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

8.  Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia.

Authors:  Alison R Walker; Rebecca Klisovic; Jeffrey S Johnston; Yao Jiang; Susan Geyer; Cheryl Kefauver; Philip Binkley; John C Byrd; Michael R Grever; Ramiro Garzon; Mitch A Phelps; Guido Marcucci; Kristie A Blum; William Blum
Journal:  Leuk Lymphoma       Date:  2013-01-24

Review 9.  Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

Authors:  Alison Donnelly; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

10.  Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells.

Authors:  Reuben H Kim; Roy Kim; Wei Chen; Shen Hu; Ki-Hyuk Shin; No-Hee Park; Mo K Kang
Journal:  Carcinogenesis       Date:  2008-09-26       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.